Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib

Mise à jour : Il y a 4 ans
Référence : NCT01217034

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to evaluate the safety and efficacy of the combination therapy with Transcatheter Arterial Chemoembolization (TACE) and sorafenib compared to TACE alone in patients with unresectable hepatocellular carcinoma (HCC) who are not candidates for surgical resection or percutaneous ablation therapy.


Critère d'inclusion

  • Hepatocellular carcinoma,Unresectable Hepatocellular Carcinoma,Carcinoma, hepatocellular,Liver neoplasm

Liens